These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 35779614)

  • 21. The role of iron in restless legs syndrome.
    Allen RP; Earley CJ
    Mov Disord; 2007; 22 Suppl 18():S440-8. PubMed ID: 17566122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restless legs syndrome: From clinic to personalized medicine.
    Chenini S; Barateau L; Dauvilliers Y
    Rev Neurol (Paris); 2023 Oct; 179(7):703-714. PubMed ID: 37689536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation.
    Earley CJ; Uhl GR; Clemens S; Ferré S
    Sleep Med; 2017 Mar; 31():71-77. PubMed ID: 27539027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS).
    Allen R
    Sleep Med; 2004 Jul; 5(4):385-91. PubMed ID: 15222997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The restless legs syndrome.
    Barrière G; Cazalets JR; Bioulac B; Tison F; Ghorayeb I
    Prog Neurobiol; 2005 Oct; 77(3):139-65. PubMed ID: 16300874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathophysiology of restless legs syndrome].
    Monaca C
    Presse Med; 2010 May; 39(5):587-91. PubMed ID: 20346613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New paradigms in the treatment of restless legs syndrome.
    Thorpy MJ
    Neurology; 2005 Jun; 64(12 Suppl 3):S28-33. PubMed ID: 15994221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic Treatment of Restless Legs Syndrome.
    Lv Q; Wang X; Asakawa T; Wang XP
    Curr Neuropharmacol; 2021; 19(3):372-382. PubMed ID: 33380302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron and restless legs syndrome: treatment, genetics and pathophysiology.
    Connor JR; Patton SM; Oexle K; Allen RP
    Sleep Med; 2017 Mar; 31():61-70. PubMed ID: 28057495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restless legs syndrome: An overview of pathophysiology, comorbidities and therapeutic approaches (Review).
    Vlasie A; Trifu SC; Lupuleac C; Kohn B; Cristea MB
    Exp Ther Med; 2022 Feb; 23(2):185. PubMed ID: 35069866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Restless-legs syndrome].
    Karroum E; Konofal E; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):701-21. PubMed ID: 18656214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In search of alternatives to dopaminergic ligands for the treatment of restless legs syndrome: iron, glutamate, and adenosine.
    Ferré S; Earley C; Gulyani S; Garcia-Borreguero D
    Sleep Med; 2017 Mar; 31():86-92. PubMed ID: 27899234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update on the pathophysiology and genetics of restless legs syndrome.
    Trotti LM; Bhadriraju S; Rye DB
    Curr Neurol Neurosci Rep; 2008 Jul; 8(4):281-7. PubMed ID: 18590611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron deficiency alters expression of dopamine-related genes in the ventral midbrain in mice.
    Jellen LC; Lu L; Wang X; Unger EL; Earley CJ; Allen RP; Williams RW; Jones BC
    Neuroscience; 2013 Nov; 252():13-23. PubMed ID: 23911809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Restless legs syndrome and periodic limb movements in sleep: pathophysiology and treatment].
    Wichniak A; Wierzbicka A; Jernajczyk W
    Neurol Neurochir Pol; 2003; 37(3):633-43. PubMed ID: 14593758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Idiopathic restless legs syndrome treatment: Progress and pitfalls?
    Ghorayeb I
    Adv Pharmacol; 2019; 84():207-235. PubMed ID: 31229172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imbalance between thyroid hormones and the dopaminergic system might be central to the pathophysiology of restless legs syndrome: a hypothesis.
    Pereira JC; Pradella-Hallinan M; Lins Pessoa Hd
    Clinics (Sao Paulo); 2010 May; 65(5):548-54. PubMed ID: 20535374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D and Restless Legs Syndrome: A Review of Current Literature.
    Cederberg KLJ; Silvestri R; Walters AS
    Tremor Other Hyperkinet Mov (N Y); 2023; 13():12. PubMed ID: 37034443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Putative Animal Models of Restless Legs Syndrome: A Systematic Review and Evaluation of Their Face and Construct Validity.
    Silvani A; Ghorayeb I; Manconi M; Li Y; Clemens S
    Neurotherapeutics; 2023 Jan; 20(1):154-178. PubMed ID: 36536233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging Concepts of the Pathophysiology and Adverse Outcomes of Restless Legs Syndrome.
    Romero-Peralta S; Cano-Pumarega I; García-Borreguero D
    Chest; 2020 Sep; 158(3):1218-1229. PubMed ID: 32247713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.